Juvenile polyposis syndrome

Lodewijk A A Brosens, Danielle Langeveld, W. Arnout van Hattem, Francis M Giardiello, G. Johan A Offerhaus

Research output: Contribution to journalArticle

Abstract

Juvenile polyposis syndrome is a rare autosomal dominant syndrome characterized by multiple distinct juvenile polyps in the gastrointestinal tract and an increased risk of colorectal cancer. The cumulative life-time risk of colorectal cancer is 39% and the relative risk is 34. Juvenile polyps have a distinctive histology characterized by an abundance of edematous lamina propria with inflammatory cells and cystically dilated glands lined by cuboidal to columnar epithelium with reactive changes. Clinically, juvenile polyposis syndrome is defined by the presence of 5 or more juvenile polyps in the colorectum, juvenile polyps throughout the gastrointestinal tract or any number of juvenile polyps and a positive family history of juvenile polyposis. In about 50%-60% of patients diagnosed with juvenile polyposis syndrome a germline mutation in the SMAD4 or BMPR1A gene is found. Both genes play a role in the BMP/TGF-beta signalling pathway. It has been suggested that cancer in juvenile polyposis may develop through the so-called "landscaper mechanism" where an abnormal stromal environment leads to neoplastic transformation of the adjacent epithelium and in the end invasive carcinoma. Recognition of this rare disorder is important for patients and their families with regard to treatment, follow-up and screening of at risk individuals. Each clinician confronted with the diagnosis of a juvenile polyp should therefore consider the possibility of juvenile polyposis syndrome. In addition, juvenile polyposis syndrome provides a unique model to study colorectal cancer pathogenesis in general and gives insight in the molecular genetic basis of cancer. This review discusses clinical manifestations, genetics, pathogenesis and management of juvenile polyposis syndrome.

Original languageEnglish (US)
Pages (from-to)4839-4844
Number of pages6
JournalWorld Journal of Gastroenterology
Volume17
Issue number44
DOIs
StatePublished - Nov 28 2011

Fingerprint

Polyps
Colorectal Neoplasms
Gastrointestinal Tract
Epithelium
Germ-Line Mutation
Transforming Growth Factor beta
Genes
Juvenile polyposis syndrome
Molecular Biology
Neoplasms
Histology
Mucous Membrane
Carcinoma

Keywords

  • BMPR1A
  • Colorectal cancer
  • Hamartoma
  • Juvenile polyposis syndrome
  • SMAD4

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Brosens, L. A. A., Langeveld, D., van Hattem, W. A., Giardiello, F. M., & Offerhaus, G. J. A. (2011). Juvenile polyposis syndrome. World Journal of Gastroenterology, 17(44), 4839-4844. https://doi.org/10.3748/wjg.v17.i44.4839

Juvenile polyposis syndrome. / Brosens, Lodewijk A A; Langeveld, Danielle; van Hattem, W. Arnout; Giardiello, Francis M; Offerhaus, G. Johan A.

In: World Journal of Gastroenterology, Vol. 17, No. 44, 28.11.2011, p. 4839-4844.

Research output: Contribution to journalArticle

Brosens, LAA, Langeveld, D, van Hattem, WA, Giardiello, FM & Offerhaus, GJA 2011, 'Juvenile polyposis syndrome', World Journal of Gastroenterology, vol. 17, no. 44, pp. 4839-4844. https://doi.org/10.3748/wjg.v17.i44.4839
Brosens LAA, Langeveld D, van Hattem WA, Giardiello FM, Offerhaus GJA. Juvenile polyposis syndrome. World Journal of Gastroenterology. 2011 Nov 28;17(44):4839-4844. https://doi.org/10.3748/wjg.v17.i44.4839
Brosens, Lodewijk A A ; Langeveld, Danielle ; van Hattem, W. Arnout ; Giardiello, Francis M ; Offerhaus, G. Johan A. / Juvenile polyposis syndrome. In: World Journal of Gastroenterology. 2011 ; Vol. 17, No. 44. pp. 4839-4844.
@article{781b91f5248d474ca62ce84a1447aa32,
title = "Juvenile polyposis syndrome",
abstract = "Juvenile polyposis syndrome is a rare autosomal dominant syndrome characterized by multiple distinct juvenile polyps in the gastrointestinal tract and an increased risk of colorectal cancer. The cumulative life-time risk of colorectal cancer is 39{\%} and the relative risk is 34. Juvenile polyps have a distinctive histology characterized by an abundance of edematous lamina propria with inflammatory cells and cystically dilated glands lined by cuboidal to columnar epithelium with reactive changes. Clinically, juvenile polyposis syndrome is defined by the presence of 5 or more juvenile polyps in the colorectum, juvenile polyps throughout the gastrointestinal tract or any number of juvenile polyps and a positive family history of juvenile polyposis. In about 50{\%}-60{\%} of patients diagnosed with juvenile polyposis syndrome a germline mutation in the SMAD4 or BMPR1A gene is found. Both genes play a role in the BMP/TGF-beta signalling pathway. It has been suggested that cancer in juvenile polyposis may develop through the so-called {"}landscaper mechanism{"} where an abnormal stromal environment leads to neoplastic transformation of the adjacent epithelium and in the end invasive carcinoma. Recognition of this rare disorder is important for patients and their families with regard to treatment, follow-up and screening of at risk individuals. Each clinician confronted with the diagnosis of a juvenile polyp should therefore consider the possibility of juvenile polyposis syndrome. In addition, juvenile polyposis syndrome provides a unique model to study colorectal cancer pathogenesis in general and gives insight in the molecular genetic basis of cancer. This review discusses clinical manifestations, genetics, pathogenesis and management of juvenile polyposis syndrome.",
keywords = "BMPR1A, Colorectal cancer, Hamartoma, Juvenile polyposis syndrome, SMAD4",
author = "Brosens, {Lodewijk A A} and Danielle Langeveld and {van Hattem}, {W. Arnout} and Giardiello, {Francis M} and Offerhaus, {G. Johan A}",
year = "2011",
month = "11",
day = "28",
doi = "10.3748/wjg.v17.i44.4839",
language = "English (US)",
volume = "17",
pages = "4839--4844",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "44",

}

TY - JOUR

T1 - Juvenile polyposis syndrome

AU - Brosens, Lodewijk A A

AU - Langeveld, Danielle

AU - van Hattem, W. Arnout

AU - Giardiello, Francis M

AU - Offerhaus, G. Johan A

PY - 2011/11/28

Y1 - 2011/11/28

N2 - Juvenile polyposis syndrome is a rare autosomal dominant syndrome characterized by multiple distinct juvenile polyps in the gastrointestinal tract and an increased risk of colorectal cancer. The cumulative life-time risk of colorectal cancer is 39% and the relative risk is 34. Juvenile polyps have a distinctive histology characterized by an abundance of edematous lamina propria with inflammatory cells and cystically dilated glands lined by cuboidal to columnar epithelium with reactive changes. Clinically, juvenile polyposis syndrome is defined by the presence of 5 or more juvenile polyps in the colorectum, juvenile polyps throughout the gastrointestinal tract or any number of juvenile polyps and a positive family history of juvenile polyposis. In about 50%-60% of patients diagnosed with juvenile polyposis syndrome a germline mutation in the SMAD4 or BMPR1A gene is found. Both genes play a role in the BMP/TGF-beta signalling pathway. It has been suggested that cancer in juvenile polyposis may develop through the so-called "landscaper mechanism" where an abnormal stromal environment leads to neoplastic transformation of the adjacent epithelium and in the end invasive carcinoma. Recognition of this rare disorder is important for patients and their families with regard to treatment, follow-up and screening of at risk individuals. Each clinician confronted with the diagnosis of a juvenile polyp should therefore consider the possibility of juvenile polyposis syndrome. In addition, juvenile polyposis syndrome provides a unique model to study colorectal cancer pathogenesis in general and gives insight in the molecular genetic basis of cancer. This review discusses clinical manifestations, genetics, pathogenesis and management of juvenile polyposis syndrome.

AB - Juvenile polyposis syndrome is a rare autosomal dominant syndrome characterized by multiple distinct juvenile polyps in the gastrointestinal tract and an increased risk of colorectal cancer. The cumulative life-time risk of colorectal cancer is 39% and the relative risk is 34. Juvenile polyps have a distinctive histology characterized by an abundance of edematous lamina propria with inflammatory cells and cystically dilated glands lined by cuboidal to columnar epithelium with reactive changes. Clinically, juvenile polyposis syndrome is defined by the presence of 5 or more juvenile polyps in the colorectum, juvenile polyps throughout the gastrointestinal tract or any number of juvenile polyps and a positive family history of juvenile polyposis. In about 50%-60% of patients diagnosed with juvenile polyposis syndrome a germline mutation in the SMAD4 or BMPR1A gene is found. Both genes play a role in the BMP/TGF-beta signalling pathway. It has been suggested that cancer in juvenile polyposis may develop through the so-called "landscaper mechanism" where an abnormal stromal environment leads to neoplastic transformation of the adjacent epithelium and in the end invasive carcinoma. Recognition of this rare disorder is important for patients and their families with regard to treatment, follow-up and screening of at risk individuals. Each clinician confronted with the diagnosis of a juvenile polyp should therefore consider the possibility of juvenile polyposis syndrome. In addition, juvenile polyposis syndrome provides a unique model to study colorectal cancer pathogenesis in general and gives insight in the molecular genetic basis of cancer. This review discusses clinical manifestations, genetics, pathogenesis and management of juvenile polyposis syndrome.

KW - BMPR1A

KW - Colorectal cancer

KW - Hamartoma

KW - Juvenile polyposis syndrome

KW - SMAD4

UR - http://www.scopus.com/inward/record.url?scp=83155165469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83155165469&partnerID=8YFLogxK

U2 - 10.3748/wjg.v17.i44.4839

DO - 10.3748/wjg.v17.i44.4839

M3 - Article

C2 - 22171123

AN - SCOPUS:83155165469

VL - 17

SP - 4839

EP - 4844

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 44

ER -